Ian Wilkinson is a Clinical Pharmacologist and Professor of Therapeutics in the University of Cambridge.

He directs the Cambridge Clinical Trials Unit, and office of Translational Research, and leads the division of Experimental Medicine and Immunotherapeutics at the University of Cambridge. His main research interests are clinical/experimental studies designed to understand the mechanisms causing hypertension and cardiovascular disease, and to develop new treatments.

He is lead investigator on the MRC/BHF-funded AIMHY-INFORM trial, which will determine the most effective antihypertensive treatment for different ethnic groups in the UK, and a number of early phase trials run in collaboration with Industry partners.

Professor Wilkinson also leads the Cambridge Experimental Medicine Training Initiative – which aims to create the next generation of clinical researchers to develop the medicines of the future.